Winton Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-79,264
| Closed | -$4.81M | – | 1197 |
|
|
2026
Q1 | $4.81M | Buy |
79,264
+60,481
| +322% | +$3.53M | 0.17% | 165 |
|
|
2025
Q4 | $1.01M | Buy |
+18,783
| New | +$904K | 0.04% | 478 |
|
|
2024
Q4 | – | Sell |
-5,551
| Closed | -$287K | – | 624 |
|
|
2024
Q3 | $287K | Buy |
+5,551
| New | +$260K | 0.02% | 524 |
|
|
2024
Q2 | – | Sell |
-6,771
| Closed | -$367K | – | 588 |
|
|
2024
Q1 | $367K | Buy |
+6,771
| New | +$345K | 0.03% | 509 |
|
|
2023
Q2 | – | Sell |
-8,793
| Closed | -$609K | – | 798 |
|
|
2023
Q1 | $609K | Sell |
8,793
-31,172
| -78% | -$2.2M | 0.04% | 618 |
|
|
2022
Q4 | $2.88M | Buy |
39,965
+23,328
| +140% | +$1.76M | 0.19% | 121 |
|
|
2022
Q3 | $1.18M | Sell |
16,637
-48,070
| -74% | -$3.49M | 0.08% | 353 |
|
|
2022
Q2 | $4.98M | Buy |
+64,707
| New | +$4.93M | 0.26% | 72 |
|
|
2019
Q1 | – | Sell |
-94,618
| Closed | -$4.92M | – | 1083 |
|
|
2018
Q4 | $4.92M | Buy |
94,618
+89,906
| +1,908% | +$4.83M | 0.11% | 265 |
|
|
2018
Q3 | $293K | Sell |
4,712
-279
| -6% | -$16.6K | 0.01% | 827 |
|
|
2018
Q2 | $276K | Sell |
4,991
-5,877
| -54% | -$317K | 0.01% | 862 |
|
|
2018
Q1 | $687K | Buy |
10,868
+420
| +4% | +$27K | 0.02% | 639 |
|
|
2017
Q4 | $640K | Sell |
10,448
-7,724
| -43% | -$483K | 0.02% | 444 |
|
|
2017
Q3 | $1.16M | Buy |
18,172
+13,880
| +323% | +$810K | 0.04% | 390 |
|
|
2017
Q2 | $239K | Buy |
+4,292
| New | +$234K | 0.01% | 584 |
|
|
2016
Q3 | – | Sell |
-4,746
| Closed | -$349K | – | 383 |
|
|
2016
Q2 | $349K | Buy |
+4,746
| New | +$335K | 0.01% | 289 |
|
|
2016
Q1 | – | Sell |
-5,830
| Closed | -$401K | – | 315 |
|
|
2015
Q4 | $401K | Sell |
5,830
-264,815
| -98% | -$17.5M | ﹤0.01% | 308 |
|
|
2015
Q3 | $16M | Buy |
270,645
+155,666
| +135% | +$9.88M | 0.13% | 259 |
|
|
2015
Q2 | $7.65M | Buy |
114,979
+106,938
| +1,330% | +$7.05M | 0.07% | 295 |
|
|
2015
Q1 | $519K | Buy |
8,041
+2,749
| +52% | +$172K | ﹤0.01% | 398 |
|
|
2014
Q4 | $312K | Sell |
5,292
-322,426
| -98% | -$18.2M | ﹤0.01% | 584 |
|
|
2014
Q3 | $16.8M | Sell |
327,718
-405,782
| -55% | -$20.3M | 0.12% | 276 |
|
|
2014
Q2 | $35.6M | Buy |
+733,500
| New | +$36.1M | 0.24% | 174 |
|
Other funds holding BMY
VCM
VPM
Winton Group's BMY Position: Q2 2026 in Review
Winton Group sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 79,264 shares — an estimated $4.81M sold.
Winton Group first reported a position in BMY in Q2 2014 and held it in 23 quarters. The position peaked at $35.6M in Q2 2014. 2,142 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Winton Group reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Winton Group sold 79,264 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.81M.
- Winton Group first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 23 quarters.
- Winton Group's Bristol-Myers Squibb position peaked at $35.6M in Q2 2014.
- 2,142 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.